Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.01B.
ENTERPRISE VALUE (EV)
$2.01B
Maravai LifeSciences Holdings, Inc.
Market Cap
$2.19B
Enterprise Value (EV)
$2.01B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Maravai LifeSciences Holdings, Inc. (MRVI) | $2.19B | $2.01B |
| Pharvaris N.V. (PHVS)vs › | $2.16B | $1.80B |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.23B | $2.15B |
| GeneDx Holdings Corp. (WGS)vs › | $2.13B | $2.23B |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | $1.97B |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | $2.12B |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | $1.88B |
| Vera Therapeutics, Inc. (VERA)vs › | $2.08B | $2.10B |
| Alvotech (ALVO)vs › | $2.07B | $3.38B |
| Liquidia Corporation (LQDA)vs › | $2.30B | $2.15B |
Market Cap
$2.19B
Total Debt
$35.58M
Cash
$216.89M
Enterprise Value
$2.01B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
